IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
Foci of chondrocyte hypertrophy that commonly develop in osteoarthritic (OA) cartilage can promote dysregulated matrix repair and pathologic calcification in OA. The closely related chemokines IL-8/CXCL8 and growth-related oncogene alpha (GROalpha)/CXCL1 and their receptors are up-regulated in OA cartilage chondrocytes. Because these chemokines regulate leukocyte activation through p38 mitogen-activated protein kinase signaling, a pathway implicated in chondrocyte hypertrophic differentiation, we tested whether IL-8 and GROalpha promote chondrocyte hypertrophy. We observed that normal human and bovine primary articular chondrocytes expressed both IL-8Rs (CXCR1, CXCR2). IL-8 and the selective CXCR2 ligand GROalpha (10 ng/ml) induced tissue inhibitor of metalloproteinase-3 expression, markers of hypertrophy (type X collagen and MMP-13 expression, alkaline phosphatase activity), as well as matrix calcification. IL-8 and the selective CXCR2 ligand GROalpha also induced increased transamidation activity of chondrocyte transglutaminases (TGs), enzymes up-regulated in chondrocyte hypertrophy that have the potential to modulate differentiation and calcification. Under these conditions, p38 mitogen-activated protein kinase pathway signaling mediated induction of both type X collagen and TG activity. Studies using mouse knee chondrocytes lacking one of the two known articular chondrocyte-expressed TG isoenzymes (TG2) demonstrated that TG2 was essential for murine GROalpha homologue KC-induced TG activity and critically mediated induction by KC of type X collagen, matrix metalloproteinase-13, alkaline phosphatase, and calcification. In conclusion, IL-8 and GROalpha induce articular chondrocyte hypertrophy and calcification through p38 and TG2. Our results suggest a novel linkage between inflammation and altered differentiation of articular chondrocytes. Furthermore, CXCR2 and TG2 may be sites for intervention in the pathogenesis of OA.
Merz
Denise
D
Veterans Affairs Medical Center, University of California at San Diego, La Jolla 92161, USA.
Liu
Ru
R
Johnson
Kristen
K
Terkeltaub
Robert
R
D000818:Animals; D002358:Cartilage, Articular / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D002417:Cattle; D002454:Cell Differentiation / Q000276:immunology; D002478:Cells, Cultured; D054360:Chemokine CXCL1; D018925:Chemokines / Q000502:physiology*; D019743:Chemokines, CXC / Q000378:metabolism* / Q000502:physiology*; D002630:Chemotactic Factors / Q000502:physiology*; D019902:Chondrocytes / Q000201:enzymology / Q000276:immunology* / Q000473:pathology*; D016207:Cytokines / Q000502:physiology; D019204:GTP-Binding Proteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D006801:Humans; D006984:Hypertrophy; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology*; D016209:Interleukin-8 / Q000378:metabolism / Q000502:physiology*; D008024:Ligands; D020935:MAP Kinase Signaling System / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D011503:Transglutaminases / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases
C475896:CXCL1 protein, Bos taurus; C475829:CXCL1 protein, human; D054360:Chemokine CXCL1; D018925:Chemokines; D019743:Chemokines, CXC; D002630:Chemotactic Factors; C475895:Cxcl1 protein, mouse; D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins; D016209:Interleukin-8; D008024:Ligands; C074302:keratinocyte-derived chemokines; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D011503:Transglutaminases; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D019204:GTP-Binding Proteins